These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17040617)

  • 1. Evaluation of the clinical utility of diagnostic versus therapeutic interventions in oncology: related but quite different processes.
    Markman M
    Curr Oncol Rep; 2006 Nov; 8(6):407-8. PubMed ID: 17040617
    [No Abstract]   [Full Text] [Related]  

  • 2. Using evaluations of diagnostic tests: understanding their limitations and making the most of available evidence.
    Deeks JJ
    Ann Oncol; 1999 Jul; 10(7):761-8. PubMed ID: 10470421
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of molecular pathology in oncology: the clinician's perspective.
    Grade M; Becker H; Ghadimi BM
    Cell Oncol; 2004; 26(5-6):275-8. PubMed ID: 15623937
    [No Abstract]   [Full Text] [Related]  

  • 4. [Imperatives and possibilities in the informatics of therapeutic decision making in oncology. II].
    Bild E
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(4):777-82. PubMed ID: 2636780
    [No Abstract]   [Full Text] [Related]  

  • 5. Seeing into cells. The promise of in vivo molecular imaging in oncology.
    Sullivan DC; Kelloff G
    EMBO Rep; 2005 Apr; 6(4):292-6. PubMed ID: 15809653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Companion diagnostics in oncology - current status and future aspects.
    Jørgensen JT
    Oncology; 2013; 85(1):59-68. PubMed ID: 23860090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor heterogeneity has considerable importance for the oncology practice].
    Versicherungsmedizin; 2013 Mar; 65(1):52-3. PubMed ID: 23593823
    [No Abstract]   [Full Text] [Related]  

  • 8. Does global oncology need artificial intelligence?
    Gyawali B
    Lancet Oncol; 2018 May; 19(5):599-600. PubMed ID: 29726374
    [No Abstract]   [Full Text] [Related]  

  • 9. 2015 ASCO Annual Meeting.
    Coburn C
    Lancet Oncol; 2015 Jul; 16(7):755-6. PubMed ID: 26062778
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurologists and neuro-oncology.
    Rees J
    Trans Med Soc Lond; 2010-2011; 127():63-71. PubMed ID: 24941643
    [No Abstract]   [Full Text] [Related]  

  • 11. Introducing the clinical connection.
    Anderson KC
    Clin Cancer Res; 2007 Jul; 13(13):3761. PubMed ID: 17606703
    [No Abstract]   [Full Text] [Related]  

  • 12. Telomeres and telomerase. A survey about methods and recent advances in cancer diagnostic and therapy.
    Weise JM; Günes C
    Histol Histopathol; 2006 Nov; 21(11):1249-61. PubMed ID: 16874667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient-centered team approach in oncology.
    Wu CS; El-Rayes BF
    Cancer; 2018 May; 124(9):1856-1858. PubMed ID: 29633252
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction to special issue on biomarker-based clinical trial designs in oncology.
    Sargent DJ; Mandrekar S; Grothey A
    Chin Clin Oncol; 2015 Sep; 4(3):28. PubMed ID: 26408295
    [No Abstract]   [Full Text] [Related]  

  • 15. Where adolescents and young adults with cancer receive their care: does it matter?
    Pollock BH
    J Clin Oncol; 2007 Oct; 25(29):4522-3. PubMed ID: 17925546
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase 0 clinical studies in oncology.
    Collins JM
    Clin Pharmacol Ther; 2009 Feb; 85(2):204-7. PubMed ID: 19109589
    [No Abstract]   [Full Text] [Related]  

  • 17. Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.
    Schnipper LE; Davidson NE; Wollins DS; Blayney DW; Dicker AP; Ganz PA; Hoverman JR; Langdon R; Lyman GH; Meropol NJ; Mulvey T; Newcomer L; Peppercorn J; Polite B; Raghavan D; Rossi G; Saltz L; Schrag D; Smith TJ; Yu PP; Hudis CA; Vose JM; Schilsky RL
    J Clin Oncol; 2016 Aug; 34(24):2925-34. PubMed ID: 27247218
    [No Abstract]   [Full Text] [Related]  

  • 18. Expectations to Patient-Reported Outcome (PRO) in Oncology - PRO for a purpose, when and how?
    Pappot H; Taarnhøj GA
    Acta Oncol; 2020 Jun; 59(6):611-612. PubMed ID: 32253960
    [No Abstract]   [Full Text] [Related]  

  • 19. [Oncological intensive care: 2011 year's review].
    Sculier JP; Berghmans T; Meert AP
    Rev Med Brux; 2012; 33(6):540-4. PubMed ID: 23373125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative mathematical oncology.
    Anderson AR; Quaranta V
    Nat Rev Cancer; 2008 Mar; 8(3):227-34. PubMed ID: 18273038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.